We started Samphire Neuroscience to build a world where women everywhere have access to scientifically validated wearable technology for their health needs, without having to sacrifice on technology, design or lifestyle.Building on more than thirty years of research and clinical experience, we are developing wearable neurotechnology, the Samphire Headband, that addresses a range of menstrual-cycle related challenges.Want to know more? Reach out to us via founders@samphireneuro.com

SOSV

Ayuh Ventures

Samphire Neuroscience

Domain Not Resolving

DNSSEC

Amazon

HSTS IncludeSubdomains PreLoad

Next.js

Google Cloud Functions

PayPal JavaScript SDK

PayPal Marketing Solutions

PayPal Button

Intercom

Engineering Lead

Ervinas Bernatavicius

Health Care Companies With Fewer Than 1000 Employees (Top 10K)

Wellness Companies With Fewer Than 100 Employees (Top 10K)

Europe, Middle East, and Africa (EMEA) Seed Stage Companies With Fewer Than 50 Employees (Top 10K)

PharmStars Portfolio Companies

Samphire Neuroscience provides solutions that specialize in women's health. The company was founded in 2021 and is based in London, England.

Pre Seed Round - Samphire Neuroscience

PharmStars

Non Equity Assistance - Samphire Neuroscience

Convertible Note - Samphire Neuroscience

Computer and Software Products and Electrical and Scientific Products

London

England

United Kingdom

Europe

Samphire Neuroscience’s $2.3 Million Pre-Seed Round

Samphire Neuroscience's $2.3 Million Pre-Seed Round – Global Legal Chronicle

London-based Samphire Neuroscience raises €2.1 million to launch wearable that targets PMS and menstrual pain

This startup raised $2.3M to tackle PMS and period pain using neurotechnology wearable — TFN

This headband stimulates your brain to get rid of period pains

Samphire Neuroscience secures $2.3M Pre-Seed to launch menstrual health wearable

Startup developing wearable to tackle period pain raises £1.8m

A medical-grade, at-home wearable device that uses transcranial direct current stimulation (tDCS) to manage PMS and menstrual pain by targeting brain regions responsible for pain perception and mood regulation.

Clinical-grade solutions being developed in collaboration with the Lithuanian National Psychiatric Hospital to address post-natal depression.

Clinical-grade solutions being developed in collaboration with Imperial College London to manage common symptoms experienced during menopause.

The Netherlands

Taiwan

Asia

Argentina

South America

United States

North America

Pakistan

Flo Health focuses on female health, specifically in the domain of reproductive health and wellness.

Flo Health

Samphire Neuroscience is a privately held medical equipment manufacturing company based in London. They specialize in developing wearable neurotechnology, specifically the Samphire Headband, to address a range of menstrual-cycle related challenges. Their focus is on women's wellness, menstrual cycle health, and related conditions such as dysmenorrhea, premenstrual syndrome (PMS), and menstrual migraine.

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general	Feb 21, 2024 7:17 PM	fe7110d6
public peers	general
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Feb 21, 2024 7:17 PM	a32467b5
company summary	general
signals	general
crunchbase trigger	general	Nov 22, 2024 7:44 AM	159da20d
crunchbase profile	general	Nov 22, 2024 8:49 AM	0e993e60
li profile	general	Feb 21, 2024 7:17 PM	2a6fe8c4
translate crunchbase fundingrounds	general	Nov 22, 2024 10:54 AM	99e9d1fa
peers	general
news basic	general	Feb 21, 2024 7:17 PM	cbff3b98
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:SAMPHIRENEURO

Samphire Neuroscience